Epidemiologic HIV/AIDS Research Among African American and Hispanic Women at Risk for HIV Infection in the Southern United States and Puerto Rico; Notice of Availability of Funds-Amendment, 38149-38150 [05-13011]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 126 / Friday, July 1, 2005 / Notices
Individual records of the following HHS
Operating Divisions may be obtained from
the Program Support Center (PSC):
1. Administration for Children and
Families (ACF)
2. Administration on Aging (AoA)
3. Agency for Health Care Policy and
Research (AHCPR)
4. Health Resources and Services
Administration (HRSA)
5. Indian Health Service (IHS)
6. Substance Abuse and Mental Health
Services Administration (SAMHSA)
7. Office of the Secretary (OS) Substance
Abuse and Mental Health Services
Administration (SAMHSA)
In addition to the individual records
maintained by the PSC, travel-related records
for SAMHSA employees may also be
obtained from the following SAMHSA
program offices:
Office of the Administrator, Substance Abuse
and Mental Health Services
Administration, 1 Choke Cherry Road,
Room 8–1054, Rockville, MD 20857
Office of Applied Studies, Substance Abuse
and Mental Health Services
Administration, 1 Choke Cherry Road,
Room 7–1047, Rockville, MD 20857
Office of Program Services, Division of
Administrative Services, Substance Abuse
and Mental Health Services
Administration, 1 Choke Cherry Road,
Room 7–1073, Rockville, MD 20857
Center for Substance Abuse Prevention,
Substance Abuse and Mental Health
Services Administration, 1 Choke Cherry
Road Room 4–1051, Rockville, MD 20857
Center for Substance Abuse Treatment,
Substance Abuse and Mental Health
Services Administration, 1 Choke Cherry
Road, Room 5–1015, Rockville, MD 20857
Center for Mental Health Services, Substance
Abuse and Mental Health Services
Administration, 1 Choke Cherry Road,
Room 6–1051, Rockville, MD 20857
[FR Doc. 05–13050 Filed 6–30–05; 8:45 am]
BILLING CODE 4150–24–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Request for Application (RFA) PS05–107]
Epidemiologic HIV/AIDS Research
Among African American and Hispanic
Women at Risk for HIV Infection in the
Southern United States and Puerto
Rico; Notice of Availability of FundsAmendment
A notice announcing the availability
of Fiscal Year (FY) 2005 funds to award
a Cooperative Agreement for
Epidemiologic HIV/AIDS Research
among African American and Hispanic
Women at Risk for HIV Infection in the
Southern United States and Puerto Rico
was published in the Federal Register,
VerDate jul<14>2003
18:11 Jun 30, 2005
Jkt 205001
June 1, 2005, Volume 70, Number 104,
pages 31472–31477.
The notice is amended as follows:
On page 31472, Second column,
please change application deadline date
to: July 22, 2005.
On page 31473, First column, first
paragraph, twelfth line, following the
sentence: ‘‘Applicants should indicate
clearly whether their application
pertains to Hispanic or African
American women’’; please insert the
following sentence: ‘‘Applicants should
select a target population comprised of
only Hispanic or African American
women, not both.’’
On page 31473, Third column,
Section II. Award Information,
Approximate Average Award, following
the sentence: ‘‘This amount is for the
first 12-month budget period’’; please
insert the following: ‘‘this includes both
indirect and direct costs.’’
On page 31474, First column, Section
III.3 Other, following the bullet:
‘‘Priority will be given to applications
that include two site investigators—a
senior research investigator (10 percent
full time effort) and a junior research
investigator (30 percent full time effort,
who will serve as the primary site
investigator)—with direct links to or
involvement with the specified study
population’’; please insert the following
sentence: ‘‘Applicants who are unable to
meet these criteria may apply, but must
include one research investigator with
demonstrated direct links to or
involvement with specified study
population who can commit at least 30
percent full time effort during the major
phases of this research.’’
On page 31475, First column, Section
IV.2, Content and Form of Application
Submission, after the first paragraph,
please insert the following in a new
paragraph: ‘‘Applicants should provide
budgets for four years, but take into
account that the first 18 months will be
predominantly protocol development (3
months) and IRB and Office of
Management and Budget (OMB) review
(12–18 months) and will not require full
staffing and thus funding will be
restricted. Enrollment of the 300–500
women will occur following IRB/OMB
approval and is estimated to take 9–12
months. The qualitative component will
follow the cross-sectional study.
Budgets should contain laboratory costs
to cover purchase/processing of rapid
oral HIV tests, confirmatory HIV testing,
urine testing for gonorrhea and
chlamydia, and anticipated costs for
shipping of specimens to the CDCdesignated laboratory in New York state
for STARHS testing.’’
On page 31475, First column, IV.3.
Submission Dates and Times,
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
38149
Explanation of Deadlines, please delete
the first sentence and replace with:
‘‘LOIs must be received by the CDC
Project Officer and applications must be
received in the CDC Procurements and
Grants Office by 4 p.m. Eastern Time on
the deadline date.’’
On page 31475, First column, IV.3.
Submission Dates and Times, please
change application deadline date to:
July 22, 2005.
On page 31475, Second column, IV.3.
Submission Dates and Times,
Explanation of Deadlines, last
paragraph, please delete the third
sentence and replace with: ‘‘If you still
have a question concerning your LOI,
contact the CDC Project Officer at 404–
639–6117.’’
On page 31475, Third column, IV.6
Other Submission Requirements, please
delete the following: ‘‘Submit your LOI
by express mail , delivery service, fax,
or E-mail to: Mary Lerchen, DrPH
(PS05–107), Scientific Review
Administrator, CDC/Office of Public
Health Research, 1 West Court Square,
Suite 7000, Mailstop D–72, Decatur,
Georgia 30030, Telephone: 404–371–
5277, Fax 404–371–5215, E-mail:
MLerchen@cdc.gov’’; and replace with:
‘‘Submit your LOI by mail, fax, or Email to: Marta Ackers, MD (PS05–107),
Project Officer, CDC, NCHSTP, DHAP–
SE; 1600 Clifton Road, Mailstop E–45,
Atlanta, Georgia 30333, Telephone:
404–639–6117, Fax 404–639–6127, Email: MAckers@cdc.gov.’’
On page 31475, Third column, IV.6.
Other Submission Requirements, second
paragraph, under Application
Submission Address, please delete the
following: ‘‘Submit the original and one
hard copy * * * ’’, and insert: ‘‘Submit
the original and four hard copies
* * * ’’
On page 31475, Third column, IV.6.
Other Submission Requirements, please
delete the third paragraph in its entirety.
On page 31475, Third column,
Section V.1. Criteria, please delete the
third paragraph in its entirety and
replace with the following: ‘‘Each
application will be evaluated
individually against the following
criteria by a scientific review group
appointed by CDC. Applications will be
ranked on a scale of 100 maximum
points. Applications will be reviewed
and evaluated based on the evidence
submitted and the applicant’s abilities
to meet the following criteria:’’
On page 31476, First and Second
column, Section V.1. Criteria, please
attach the following points to each
review criteria: Significance (5 points);
Approach (50 points); Innovation (5
points); Investigator (30 points); and
Environment (10 points).
E:\FR\FM\01JYN1.SGM
01JYN1
38150
Federal Register / Vol. 70, No. 126 / Friday, July 1, 2005 / Notices
On pages 31476 and 31477, Third and
First columns respectively, V.2. Review
and Selection Process, please delete all
the information in this section and
replace with the following:
‘‘Applications will be reviewed for
completeness by the Procurement and
Grants Office (PGO) staff, and for
responsiveness by NCHSTP. Incomplete
applications and applications that are
non-responsive to the eligibility criteria
will not advance through the review
process. Applicants will be notified that
their application did not meet
submission requirements.’’
On page 31477, Second column, VII.
Agency Contacts, please delete the
following: ‘‘For scientific/research
issues, contact: Amy L. Sandul, Health
Science Administrator, Centers for
Disease Control and Prevention,
National Center for HIV, STD, and TB
Prevention, 1600 Clifton Road, NE., MS
E–07, Atlanta, GA 30333, Telephone:
404–639–6485, E-mail:
ASandul@cdc.gov’’; and replace with:
‘‘For scientific/research issues contact:
Marta Ackers, MD, Project Officer, 1600
Clifton Road, Mailstop E–45, Atlanta,
Georgia 30333, Telephone: 404–639–
6117, Fax 404–639–6127, E-mail:
MAckers@cdc.gov.’’
On page 31477, Second column, VIII.
Agency Contacts, please delete the
following: ‘‘For questions about peer
review, contact: Mary Lerchen, DrPH,
Scientific Review Administrator,
Centers for Disease Control and
Prevention, 1 West Court Square, Suite
7000, Mailstop D–72, Decatur, Georgia
30030, Telephone: 404–371–5277, Fax
404–371–5215, E-mail: mlerchen
@cdc.gov’’; and replace with: ‘‘For
questions about objective review,
contact: Beth Wolfe, Centers for Disease
Control and Prevention, 1600 Clifton
Road, Mailstop E–07, Atlanta, GA
30333; Telephone: 404–639–8531, Email: eow1@cdc.gov’’.
Dated: June 27, 2005.
Alan A. Kotch,
Director, Procurement and Grants Office,
Centers for Disease Control and Prevention.
[FR Doc. 05–13011 Filed 6–30–05; 8:45 am]
BILLING CODE 4163–18–P
VerDate jul<14>2003
18:11 Jun 30, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Request for Application (RFA) PS05–083]
Adaptation and Evaluation of a Brief,
Nurse-Delivered Sexual Risk
Reduction Intervention for HIV-Positive
Women in the South; Notice of
Availability of Funds—Amendment
A notice announcing the availability
of Fiscal year (FY) 2005 funds to award
a Cooperative Agreement for Adaptation
and Evaluation of a Brief, NurseDelivered Sexual Risk Reduction
Intervention for HIV-Positive Women in
the South published in the Federal
Register, on June 3, 2005, Volume 70,
Number 106, pages 32624–32629].
The notice is amended as follows: On
page 32624, Third column, please
change application deadline date to:
July 22, 2005.
On page 32627, First column, Section
IV.2 Content and Form of Application
Submission, please delete the following:
‘‘This announcement uses the modular
budgeting as well as non-modular
budgeting formats. See:
https://grants.nih.gov/grants/funding/
modular/modular.htm for additional
guidance on modular budgets.
Specifically, if you are submitting an
application with direct costs in each
year of $250,000 or less, use the
modular budget format. Otherwise,
follow the instructions for non-modular
budget research grant applications’’; and
replace with the following sentence:
‘‘This announcement uses the nonmodular budgeting format.’’
On page 32627, First column, Section
IV.3. Submission Dates and Times,
please change application deadline date
to: July 22, 2005.
On page 32627, Second column,
Section IV.6. Other Submission
Requirements, please delete the
following: ‘‘Submit you LOI by express
mail or delivery service to: Mary
Lerchen, DrPH, Scientific Review
Administrator, Centers for Disease
Control and Prevention, One West Court
Square, Suite 7000, MS D–72, Decatur,
GA 30030, Telephone: 404–371–5277,
Fax: 404–371–5215, Email:
Mlerchen@cdc.gov’’; and replace with
the following: ‘‘Submit your LOI by
express mail or delivery service to: Kim
Williams PhD, Project Officer, 1600
Clifton Road NE., M.S. E–37, Atlanta,
GA 30333, Telephone: 404–639–6157,
Fax: 404–639–1950, E-mail:
ktw5@cdc.gov.’’
On page 32627, Third column,
Section IV.6. Other Submission
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Requirements, please delete the
following: ‘‘At the time of submission,
four additional copies of the application
and all appendices must be sent to:
Mary Lerchen, DrPH, Scientific Review
Administrator, Centers for Disease
Control and Prevention, One West Court
Square, Suite 7000, MS DZ–27, Decatur,
GA 30030, Telephone: 404–371–5277,
Fax: 404–371–5215, E-mail:
Mlerchen@cdc.gov.’’
On page 32627, Third column and on
page 32628, First and Second columns,
Section V.1 Criteria, delete the
following: ‘‘The goals of CDC-supported
research are to advance the
understanding of biological systems,
improve the control and prevention of
disease and injury, and enhance health.
In the written comments, reviewers will
be asked to evaluate the application in
order to judge the likelihood that the
proposed research will have a
substantial impact on the pursuit of the
goals appropriate to this announcement.
The scientific review group will
address and consider each of the
following criteria in assigning the
application’s overall score, weighting
them as appropriate for each
application. The application does not
need to be strong in all categories to be
judged likely to have major scientific
impact and thus deserve a high priority
score. For example, an investigator may
propose to carry out important work
that by its nature is not innovative, but
is essential to move a field forward.
The review criteria are as follows:
Significance: Does this study address
an important problem? If the aims of the
application are achieved, how will
scientific knowledge be advanced? What
will be the effect of these studies on the
concepts or methods that drive this
field? Does the applicant demonstrate
an understanding of the need for and
intent of the research? Does the
applicant provide a description of study
activities that are likely to lead to
meeting the objectives of this project?
Are the proposed study activities likely
to have a positive impact on the field of
HIV prevention for HIV positive women
in the southern U.S.?
Approach: Are the conceptual
framework, design, methods, and
analyses adequately developed, wellintegrated, and appropriate to the aims
of the project? Does the applicant
acknowledge potential problem areas
and consider alternative tactics? Does
the applicant address all of the activities
listed on pages four through eight of this
announcement? Will the applicant
establish a community advisory board to
assist on all aspects of conducting the
study? Does the applicant agency
demonstrate adequate knowledge of the
E:\FR\FM\01JYN1.SGM
01JYN1
]]>Agencies
[Federal Register Volume 70, Number 126 (Friday, July 1, 2005)]
[Notices]
[Pages 38149-38150]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-13011]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Request for Application (RFA) PS05-107]
Epidemiologic HIV/AIDS Research Among African American and
Hispanic Women at Risk for HIV Infection in the Southern United States
and Puerto Rico; Notice of Availability of Funds-Amendment
A notice announcing the availability of Fiscal Year (FY) 2005 funds
to award a Cooperative Agreement for Epidemiologic HIV/AIDS Research
among African American and Hispanic Women at Risk for HIV Infection in
the Southern United States and Puerto Rico was published in the Federal
Register, June 1, 2005, Volume 70, Number 104, pages 31472-31477.
The notice is amended as follows:
On page 31472, Second column, please change application deadline
date to: July 22, 2005.
On page 31473, First column, first paragraph, twelfth line,
following the sentence: ``Applicants should indicate clearly whether
their application pertains to Hispanic or African American women'';
please insert the following sentence: ``Applicants should select a
target population comprised of only Hispanic or African American women,
not both.''
On page 31473, Third column, Section II. Award Information,
Approximate Average Award, following the sentence: ``This amount is for
the first 12-month budget period''; please insert the following: ``this
includes both indirect and direct costs.''
On page 31474, First column, Section III.3 Other, following the
bullet: ``Priority will be given to applications that include two site
investigators--a senior research investigator (10 percent full time
effort) and a junior research investigator (30 percent full time
effort, who will serve as the primary site investigator)--with direct
links to or involvement with the specified study population''; please
insert the following sentence: ``Applicants who are unable to meet
these criteria may apply, but must include one research investigator
with demonstrated direct links to or involvement with specified study
population who can commit at least 30 percent full time effort during
the major phases of this research.''
On page 31475, First column, Section IV.2, Content and Form of
Application Submission, after the first paragraph, please insert the
following in a new paragraph: ``Applicants should provide budgets for
four years, but take into account that the first 18 months will be
predominantly protocol development (3 months) and IRB and Office of
Management and Budget (OMB) review (12-18 months) and will not require
full staffing and thus funding will be restricted. Enrollment of the
300-500 women will occur following IRB/OMB approval and is estimated to
take 9-12 months. The qualitative component will follow the cross-
sectional study. Budgets should contain laboratory costs to cover
purchase/processing of rapid oral HIV tests, confirmatory HIV testing,
urine testing for gonorrhea and chlamydia, and anticipated costs for
shipping of specimens to the CDC-designated laboratory in New York
state for STARHS testing.''
On page 31475, First column, IV.3. Submission Dates and Times,
Explanation of Deadlines, please delete the first sentence and replace
with: ``LOIs must be received by the CDC Project Officer and
applications must be received in the CDC Procurements and Grants Office
by 4 p.m. Eastern Time on the deadline date.''
On page 31475, First column, IV.3. Submission Dates and Times,
please change application deadline date to: July 22, 2005.
On page 31475, Second column, IV.3. Submission Dates and Times,
Explanation of Deadlines, last paragraph, please delete the third
sentence and replace with: ``If you still have a question concerning
your LOI, contact the CDC Project Officer at 404-639-6117.''
On page 31475, Third column, IV.6 Other Submission Requirements,
please delete the following: ``Submit your LOI by express mail ,
delivery service, fax, or E-mail to: Mary Lerchen, DrPH (PS05-107),
Scientific Review Administrator, CDC/Office of Public Health Research,
1 West Court Square, Suite 7000, Mailstop D-72, Decatur, Georgia 30030,
Telephone: 404-371-5277, Fax 404-371-5215, E-mail: MLerchen@cdc.gov'';
and replace with: ``Submit your LOI by mail, fax, or E-mail to: Marta
Ackers, MD (PS05-107), Project Officer, CDC, NCHSTP, DHAP-SE; 1600
Clifton Road, Mailstop E-45, Atlanta, Georgia 30333, Telephone: 404-
639-6117, Fax 404-639-6127, E-mail: MAckers@cdc.gov.''
On page 31475, Third column, IV.6. Other Submission Requirements,
second paragraph, under Application Submission Address, please delete
the following: ``Submit the original and one hard copy * * * '', and
insert: ``Submit the original and four hard copies * * * ''
On page 31475, Third column, IV.6. Other Submission Requirements,
please delete the third paragraph in its entirety.
On page 31475, Third column, Section V.1. Criteria, please delete
the third paragraph in its entirety and replace with the following:
``Each application will be evaluated individually against the following
criteria by a scientific review group appointed by CDC. Applications
will be ranked on a scale of 100 maximum points. Applications will be
reviewed and evaluated based on the evidence submitted and the
applicant's abilities to meet the following criteria:''
On page 31476, First and Second column, Section V.1. Criteria,
please attach the following points to each review criteria:
Significance (5 points); Approach (50 points); Innovation (5 points);
Investigator (30 points); and Environment (10 points).
[[Page 38150]]
On pages 31476 and 31477, Third and First columns respectively,
V.2. Review and Selection Process, please delete all the information in
this section and replace with the following: ``Applications will be
reviewed for completeness by the Procurement and Grants Office (PGO)
staff, and for responsiveness by NCHSTP. Incomplete applications and
applications that are non-responsive to the eligibility criteria will
not advance through the review process. Applicants will be notified
that their application did not meet submission requirements.''
On page 31477, Second column, VII. Agency Contacts, please delete
the following: ``For scientific/research issues, contact: Amy L.
Sandul, Health Science Administrator, Centers for Disease Control and
Prevention, National Center for HIV, STD, and TB Prevention, 1600
Clifton Road, NE., MS E-07, Atlanta, GA 30333, Telephone: 404-639-6485,
E-mail: ASandul@cdc.gov''; and replace with: ``For scientific/research
issues contact: Marta Ackers, MD, Project Officer, 1600 Clifton Road,
Mailstop E-45, Atlanta, Georgia 30333, Telephone: 404-639-6117, Fax
404-639-6127, E-mail: MAckers@cdc.gov.''
On page 31477, Second column, VIII. Agency Contacts, please delete
the following: ``For questions about peer review, contact: Mary
Lerchen, DrPH, Scientific Review Administrator, Centers for Disease
Control and Prevention, 1 West Court Square, Suite 7000, Mailstop D-72,
Decatur, Georgia 30030, Telephone: 404-371-5277, Fax 404-371-5215, E-
mail: mlerchen @cdc.gov''; and replace with: ``For questions about
objective review, contact: Beth Wolfe, Centers for Disease Control and
Prevention, 1600 Clifton Road, Mailstop E-07, Atlanta, GA 30333;
Telephone: 404-639-8531, E-mail: eow1@cdc.gov''.
Dated: June 27, 2005.
Alan A. Kotch,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 05-13011 Filed 6-30-05; 8:45 am]
BILLING CODE 4163-18-P
